291 related articles for article (PubMed ID: 22564667)
1. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome.
Vortmeyer AO; Gläsker S; Mehta GU; Abu-Asab MS; Smith JH; Zhuang Z; Collins MT; Oldfield EH
J Clin Endocrinol Metab; 2012 Jul; 97(7):2404-13. PubMed ID: 22564667
[TBL] [Abstract][Full Text] [Related]
2. Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome.
Akintoye SO; Chebli C; Booher S; Feuillan P; Kushner H; Leroith D; Cherman N; Bianco P; Wientroub S; Robey PG; Collins MT
J Clin Endocrinol Metab; 2002 Nov; 87(11):5104-12. PubMed ID: 12414879
[TBL] [Abstract][Full Text] [Related]
3. Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome.
Akintoye SO; Kelly MH; Brillante B; Cherman N; Turner S; Butman JA; Robey PG; Collins MT
J Clin Endocrinol Metab; 2006 Aug; 91(8):2960-6. PubMed ID: 16720661
[TBL] [Abstract][Full Text] [Related]
4. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission.
Freda PU; Chung WK; Matsuoka N; Walsh JE; Kanibir MN; Kleinman G; Wang Y; Bruce JN; Post KD
Pituitary; 2007; 10(3):275-82. PubMed ID: 17594522
[TBL] [Abstract][Full Text] [Related]
5. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study.
Cho EK; Kim J; Yang A; Ki CS; Lee JE; Cho SY; Jin DK
Orphanet J Rare Dis; 2016 Aug; 11(1):113. PubMed ID: 27506760
[TBL] [Abstract][Full Text] [Related]
6. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C
J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434
[TBL] [Abstract][Full Text] [Related]
7. Screening for genetic causes of growth hormone hypersecretion.
Rostomyan L; Beckers A
Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and management of growth hormone excess in patients with McCune-Albright syndrome.
Yao Y; Liu Y; Wang L; Deng K; Yang H; Lu L; Feng F; Xing B; You H; Jin Z; Wang R; Pan H; Chen S; Zhu H
Eur J Endocrinol; 2017 Mar; 176(3):295-303. PubMed ID: 28007843
[TBL] [Abstract][Full Text] [Related]
9. Surgical Management of Carney Complex-Associated Pituitary Pathology.
Lonser RR; Mehta GU; Kindzelski BA; Ray-Chaudhury A; Vortmeyer AO; Dickerman R; Oldfield EH
Neurosurgery; 2017 May; 80(5):780-786. PubMed ID: 27509071
[TBL] [Abstract][Full Text] [Related]
10. McCune-Albright syndrome with acromegaly and fibrous dysplasia associated with the GNAS gene mutation identified by sensitive PNA-clamping method.
Imanaka M; Iida K; Nishizawa H; Fukuoka H; Takeno R; Takahashi K; Kaji H; Takahashi Y; Okimura Y; Kaji H; Imanishi Y; Chihara K
Intern Med; 2007; 46(18):1577-83. PubMed ID: 17878646
[TBL] [Abstract][Full Text] [Related]
11. Genetics of pituitary adenomas.
Gadelha MR; Trivellin G; Hernández Ramírez LC; Korbonits M
Front Horm Res; 2013; 41():111-40. PubMed ID: 23652674
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
13. McCune-Albright syndrome: growth hormone and prolactin hypersecretion.
Christoforidis A; Maniadaki I; Stanhope R
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():623-5. PubMed ID: 16789626
[TBL] [Abstract][Full Text] [Related]
14. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas.
Hage M; Chaligné R; Viengchareun S; Villa C; Salenave S; Bouligand J; Letouzé E; Tosca L; Rouquette A; Tachdjian G; Parker F; Lombès M; Lacroix A; Gaillard S; Chanson P; Kamenický P
J Clin Endocrinol Metab; 2019 May; 104(5):1777-1787. PubMed ID: 30376114
[TBL] [Abstract][Full Text] [Related]
16. GNAS imprinting and pituitary tumors.
Mantovani G; Lania AG; Spada A
Mol Cell Endocrinol; 2010 Sep; 326(1-2):15-8. PubMed ID: 20398730
[TBL] [Abstract][Full Text] [Related]
17. Polyostotic fibrous dysplasia with gigantism and huge pelvic tumor: a rare case of McCune-Albright syndrome.
Sakayama K; Sugawara Y; Kidani T; Fujibuchi T; Kito K; Tanji N; Nakamura A
Int J Clin Oncol; 2011 Jun; 16(3):270-4. PubMed ID: 20878436
[TBL] [Abstract][Full Text] [Related]
18. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
19. Early surgical intervention for patients with possible clinically silent somatotroph adenoma: a case series.
Kawaguchi T; Ogawa Y; Tominaga T
J Med Case Rep; 2019 Mar; 13(1):85. PubMed ID: 30862315
[TBL] [Abstract][Full Text] [Related]
20. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.
Ronchi CL; Peverelli E; Herterich S; Weigand I; Mantovani G; Schwarzmayr T; Sbiera S; Allolio B; Honegger J; Appenzeller S; Lania AG; Reincke M; Calebiro D; Spada A; Buchfelder M; Flitsch J; Strom TM; Fassnacht M
Eur J Endocrinol; 2016 Mar; 174(3):363-72. PubMed ID: 26701869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
